Imperial College London

ProfessorFanChung

Faculty of MedicineNational Heart & Lung Institute

Professor of Respiratory Medicine
 
 
 
//

Contact

 

+44 (0)20 7594 7954f.chung Website

 
 
//

Assistant

 

Miss Carolyn Green +44 (0)20 7594 7959

 
//

Location

 

227BGuy Scadding BuildingRoyal Brompton Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Liu:2023:10.1016/j.lanwpc.2023.100826,
author = {Liu, Z and Qin, R and Hu, XJ and Liu, LJ and Xu, SQ and Shi, GC and Zhou, H and Bai, J and Zhang, CM and Qi, Y and Zhou, W and Lan, SH and Tong, J and Su, TS and Wang, Q and Yang, XY and Sun, DJ and Zhu, LM and Chen, XY and Chen, H and Xie, YP and Xiao, ZH and Chen, YB and Zhao, B and Wu, QG and Chen, WL and Li, DY and Liu, H and Cheng, AQ and Cui, ZY and Zhao, L and Li, JX and Wei, XW and Zhou, XM and Su, Z and Chung, KF and Chen, ZM and Xiao, D and Wang, C},
doi = {10.1016/j.lanwpc.2023.100826},
journal = {The Lancet Regional Health - Western Pacific},
title = {Real-world tobacco cessation practice in China: findings from the prospective, nationwide multicenter China National Tobacco Cessation Cohort Study (CNTCCS)},
url = {http://dx.doi.org/10.1016/j.lanwpc.2023.100826},
volume = {39},
year = {2023}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AB - Background: Tobacco cessation is proven to be the most effective and cost-effective strategy for smokers to reduce their risk of smoking-related disease and premature death. Providing effective, efficient, safe, and patient-centred tobacco cessation treatment to reach those who need them is a significant challenge. To date, only a few nationwide studies in China have assessed the overall clinical care practice and treatment outcome of tobacco cessation. Methods: This a prospective, nationwide, multicenter, cohort study covering all Eastern China, Northwest China, Central China, North China, Southwest China, Northeast China, and South China. Participants who were current smokers aged 18–85 years attending clinic for smoking cessation were included. All the participants were treated with 3-month cessation treatment and followed up for 3 months. Data were collected prospectively using online system. The primary outcome was 7-day point abstinence rate at 24 weeks, validated biochemically by an expired carbon monoxide level of less than 10 ppm. The participants lost to follow-up or not providing validation were included as non-abstainers. Findings: A representative sample of 3557 participants were recruited and 2943 participants were included into this analysis. These participants had mean age of 53.05 years, and 94.8% were males, with 75.8% showing symptoms of tobacco dependence. A total of 965 (32.8%) participants were treated with Bupropion + behavioural counselling, followed by 935 (31.8%) with behavioural counselling, 778 (26.4%) with Varenicline + behavioural counselling, 135 (4.6%) with alternative treatments + behavioural counselling, and 130 (4.4%) with nicotine replacement therapy (NRT) + behavioural counselling. After 3-month treatment and 3-month follow-up, 21.74% of the participants quit smoking at 24 weeks. In the multivariable-adjusted analyses, quitting smoking was significantly associated with female, higher socioeconomic status, poor health condit
AU - Liu,Z
AU - Qin,R
AU - Hu,XJ
AU - Liu,LJ
AU - Xu,SQ
AU - Shi,GC
AU - Zhou,H
AU - Bai,J
AU - Zhang,CM
AU - Qi,Y
AU - Zhou,W
AU - Lan,SH
AU - Tong,J
AU - Su,TS
AU - Wang,Q
AU - Yang,XY
AU - Sun,DJ
AU - Zhu,LM
AU - Chen,XY
AU - Chen,H
AU - Xie,YP
AU - Xiao,ZH
AU - Chen,YB
AU - Zhao,B
AU - Wu,QG
AU - Chen,WL
AU - Li,DY
AU - Liu,H
AU - Cheng,AQ
AU - Cui,ZY
AU - Zhao,L
AU - Li,JX
AU - Wei,XW
AU - Zhou,XM
AU - Su,Z
AU - Chung,KF
AU - Chen,ZM
AU - Xiao,D
AU - Wang,C
DO - 10.1016/j.lanwpc.2023.100826
PY - 2023///
TI - Real-world tobacco cessation practice in China: findings from the prospective, nationwide multicenter China National Tobacco Cessation Cohort Study (CNTCCS)
T2 - The Lancet Regional Health - Western Pacific
UR - http://dx.doi.org/10.1016/j.lanwpc.2023.100826
VL - 39
ER -